Enterprise
定价
探索 API
获取演示
开始使用
Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
Novaliq

八月 2026

八月 2026的Novaliq市场份额分析

novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on eyesol®, the first and only water-free technology worldwide for ophthalmology products.
行业: 不适用
域novaliq.com
成立年份2004
员工51 - 200
年营收$10M - $15M
总部：德国, Heidelberg
novaliq.com
Novaliq
Novaliq（包含公司地区分支机构）
  • novaliq.com
    novaliq.com
查看更多网站流量和参与度信息

Novaliq收入截至 八月 2026为 10M - 15M

Novaliq主要域名产生的收入

3 年中Novaliq主要域名的收入

Novaliq主要域名的收入

novaliq.comnovaliq.com10M - 15M
使用销售情报查看更多信息

Novaliq热门域名的总访问量

了解Novaliq市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细
novaliq.comnovaliq.com5.6K
使用销售情报查看更多信息

Novaliq热门域名的平均访问时长

分析Novaliq参与度指标。

过去 3 个月的平均访问时长

子公司明细
novaliq.comnovaliq.com00:00:10
使用销售情报查看更多信息

Novaliq热门域名的平均页面浏览量

了解Novaliq如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细
novaliq.comnovaliq.com1.62
使用销售情报查看更多信息

想要获取更深入的流量洞见？

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户，开始或停止使用技术的新潜在客户，或者获得正面报道的新潜在客户。

Novaliq 排名靠前的竞争对手（按域名）

似乎没有足够的数据。

无数据可显示

标杆分析您的数字绩效

识别高价值机会，跟踪您的表现，赢得市场。

Novaliq 采用的主要技术

这些是排名前 Novaliq 的顶级域名所使用的网站技术（按行业分列）

小部件 (7)

reCAPTCHA

reCAPTCHA

查看全部

转化和分析 (3)

Google Analytics

Google Analytics

查看全部

移动设备 (3)

Meta Viewport

Meta Viewport

查看全部

内容管理系统 (2)

WordPress

WordPress

查看全部

更多技术

8

查看全部

准备好发现优质潜在客户了吗？

借助 Similarweb 销售情报解决方案，确定任意网站使用了哪些技术来设计完美的销售宣传，并缩短销售周期。

Novaliq 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Hengrui partnered with Novaliq GmbH on Jul 1st '19.Hengrui Pharma, a globally active pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH ("Novaliq"), a biopharmaceutical company focused on first-in-class and best-in-class ophthalmic therapies based on its unique water-free EyeSol platform technology, today announced that on June 23, 2026, the Chinese National Medical Products Administration (NMPA) approved Heng Yi (0.1% cyclosporine eye drops) for the treatment of patients with dry eye disease, aiming to increase tear secretion in patients with reduced tear production and alleviate disease symptoms.
六月 30, 2026阅读更多
新闻Sonja Kroesser at Novaliq GmbH recognized as Top 25 Women Leaders in Biotechnology of 2022 on Nov 17th '22.Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol ® water-free technology, is proud to announce that today its own Sonja Kroesser, Vice President and Head of Preclinical and Clinical Development, was named as a Top 25 Women Leaders in Biotechnology of 2022 by the Healthcare Technology Report.
十一月 16, 2022阅读更多
新闻Sonja Kroesser at Novaliq GmbH recognized as Top 25 Women Leaders in Biotechnology of 2022 on Jan 17th '19.Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol ® water-free technology, is proud to announce that today its own Sonja Kroesser, Vice President and Head of Preclinical and Clinical Development, was named as a Top 25 Women Leaders in Biotechnology of 2022 by the Healthcare Technology Report.
五月 27, 2019阅读更多

查看 Novaliq 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入，您可以优化工作并达成更多交易。